Gertrude Nakigudde

ORCID: 0000-0003-2179-6645
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Breast Cancer Treatment Studies
  • Advanced Breast Cancer Therapies
  • Colorectal Cancer Screening and Detection
  • BRCA gene mutations in cancer
  • Cancer survivorship and care
  • Advances in Oncology and Radiotherapy
  • Cancer Genomics and Diagnostics
  • Intergenerational Family Dynamics and Caregiving
  • AI in cancer detection
  • Chronic Lymphocytic Leukemia Research
  • Health, psychology, and well-being
  • Family Support in Illness
  • Cancer Risks and Factors
  • Ethics in Clinical Research
  • Cervical Cancer and HPV Research
  • Palliative Care and End-of-Life Issues
  • Viral-associated cancers and disorders

Uganda Cancer Institute
2016-2024

Cancer Research Center
2016-2017

Fred Hutch Cancer Center
2016-2017

University of Illinois Chicago
2016-2017

Seattle Cancer Care Alliance
2016

Advanced Breast Cancer (ABC) comprises both locally advanced breast cancer (LABC) and metastatic (MBC) [1.Cardoso F. Costa A. Norton L. ESO-ESMO 2nd International Consensus Guidelines for (ABC2). Simultaneous publication in.Breast. 2014; 23: 489-502Abstract Full Text PDF PubMed Scopus (252) Google Scholar]. Although treatable, MBC remains virtually an incurable disease with a median overall survival (OS) of ∼3 years 5-year only ∼25% [2.Cardoso Spence D. Mertz S. et al.Global analysis...

10.1093/annonc/mdy192 article EN publisher-specific-oa Annals of Oncology 2018-05-24

To understand the role of stigma in delay cancer service engagement by women with breast Kampala, Uganda.Women Sub-Saharan African countries are twice as likely to die from high-income countries, which is largely attributable late diagnosis. While cancer-related has been identified Africa, limited research focuses on how impacts behavior patients Uganda.This qualitative study used a grounded theory approach examine illness narratives 20 survivors Uganda, gathered through semistructured...

10.1002/pon.4215 article EN Psycho-Oncology 2016-07-16

PURPOSE To guide clinicians and policymakers in three global resource-constrained settings on treating patients with metastatic breast cancer (MBC) when Maximal setting–guideline recommended treatment is unavailable. METHODS A multidisciplinary, multinational panel reviewed existing ASCO guidelines conducted modified ADAPTE formal consensus processes. RESULTS Four published resource-agnostic were adapted for settings; informing two rounds of consensus; recommendations received ≥75%...

10.1200/go.23.00285 article EN cc-by-nc-nd JCO Global Oncology 2024-01-10

Background Greater than 80% of women presenting for breast cancer treatment in Uganda have late‐stage disease, which is attributable to a dysfunctional referral system and lack recognition the early signs symptoms among primary health care providers, compounded by poor infrastructure inadequate human capacity. Improving requires systemic approach beginning with situational analysis identify systematic gaps that prevent sustainable improvements outcome. Methods The authors performed using...

10.1002/cncr.32890 article EN Cancer 2020-04-29

Most women with breast cancer in sub-Saharan Africa (SSA) are diagnosed late-staged disease. The current study assesses patient-related barriers among from a general SSA population to better understand how contribute diagnostic delays. Using convenience-based sampling, 401 Ugandan without were surveyed determine prior participation detection practices correlate prompt diagnosis. In predominantly poor (76%) and rural (75%), the median age of participants was 38. Of surveyed, 155 (46%) had...

10.1371/journal.pone.0217938 article EN cc-by PLoS ONE 2019-06-20

Among a community sample of Ugandan women, we provide information about breast cancer downstaging practices (breast self-examination, clinical examination [CBE]) and health messaging preferences across sociodemographic, care access, prior exposure factors.Convenience-based sampling was conducted to recruit women age 25 years older assess as well present early for CBE in the theoretical scenario self-detection palpable lump preferences).The 401 who participated this survey were mostly poor...

10.1200/jgo.2015.001198 article EN cc-by-nc-nd Journal of Global Oncology 2016-05-12

Background Breast cancer advocacy movements, driven by advocate‐led civil society organizations (CSOs), have proven to be a powerful force for the advancement of control in high‐income countries (HICs). However, although patient movements are growing low‐income and middle‐income (LMICs) response an increasing burden, experiences needs breast CSOs LMICs is understudied. Methods The authors conducted qualitative study using in‐depth interviews focus group discussions with 98 participants...

10.1002/cncr.32852 article EN Cancer 2020-04-29

Purpose To assess breast cancer beliefs in Uganda and determine whether these are associated with factors potentially related to nonparticipation early detection. Methods A survey open- close-ended items was conducted a community sample of Ugandan women their about cancer. Linear regression used ascertain associations between demographic detection, including socioeconomic factors, health care access, prior knowledge, personal detection practices. Results Of the 401 surveyed, most had less...

10.1200/jgo.2016.008748 article EN cc-by-nc-nd Journal of Global Oncology 2017-07-17

The purpose of this study is to determine the role family obligation stress on Ugandan women's participation in preventive breast health through receipt cancer education and check-ups.A validated survey was conducted a community sample women, providing multi-item scale assess breast-health-seeking behaviors measure (FO; range 6-18). Univariate multivariate linear regression used associations between sociodemographic factors FO. (used conjunction with robust sandwich estimator for standard...

10.1634/theoncologist.2017-0553 article EN The Oncologist 2018-08-02

Patients of African ancestry are not well-represented in cancer clinical trials despite bearing a disproportionate share mortality both United States and Africa. We describe key stakeholder perspectives priorities related to bringing early-stage Africa outline essential action steps. Increasing Diversity, Market Access, Capacity Oncology Registration Trials-Is the Answer? satellite session was organized at 2021 Accelerating Anti-Cancer Agent Development Validation Workshop. Panelists...

10.1200/go.22.00117 article EN cc-by-nc-nd JCO Global Oncology 2022-06-17

PURPOSE Breast cancer advocacy movements, driven by advocate-led civil society organizations (CSOs), have proven to be a powerful force for the advancement of control in high-income countries, playing critical role providing peer support, raising awareness, reducing stigma, educating public, funds, influencing policy, and affecting national research agendas bringing public’s concerns about policymakers medical community. patient movements are growing low- middle-income countries (LMICs)...

10.1200/go.20.63000 article EN cc-by-nc-nd JCO Global Oncology 2020-07-01
Coming Soon ...